Replies to post #88122 on Biotech Values

[DewDiligence]

The fraudulent manner in which PSDV’s management presented the Iluvien data to investors is reason enough not to invest in the stock, IMO, even at a much lower price.

Did anyone here catch the CC this afternoon?